179 related articles for article (PubMed ID: 38373977)
1. RegistrAME: the Spanish self-reported patient registry of spinal muscular atrophy.
Cattinari MG; de Lemus M; Tizzano E
Orphanet J Rare Dis; 2024 Feb; 19(1):76. PubMed ID: 38373977
[TBL] [Abstract][Full Text] [Related]
2. Observation of the natural course of type 3 spinal muscular atrophy: data from the polish registry of spinal muscular atrophy.
Lusakowska A; Jedrzejowska M; Kaminska A; Janiszewska K; Grochowski P; Zimowski J; Sierdzinski J; Kostera-Pruszczyk A
Orphanet J Rare Dis; 2021 Mar; 16(1):150. PubMed ID: 33761963
[TBL] [Abstract][Full Text] [Related]
3. Spinal muscular atrophy: survival pattern and functional status.
Chung BH; Wong VC; Ip P
Pediatrics; 2004 Nov; 114(5):e548-53. PubMed ID: 15492357
[TBL] [Abstract][Full Text] [Related]
4. Self-Reported Health-Related Quality of Life of Children with Spinal Muscular Atrophy: Preliminary Insights from a Nationwide Patient Registry in Germany.
Landfeldt E; Leibrock B; Hussong J; Thiele S; Abner S; Walter MC; Moehler E; Zemlin M; Dillmann U; Flotats-Bastardas M
J Neuromuscul Dis; 2024; 11(1):117-128. PubMed ID: 38108360
[TBL] [Abstract][Full Text] [Related]
5. The First Report of Iranian Registry of Patients with Spinal Muscular Atrophy.
Mansouri V; Heidari M; Bemanalizadeh M; Azizimalamiri R; Nafissi S; Akbari MG; Barzegar M; Moayedi AR; Badv RS; Mohamadi M; Tavasoli AR; Amirsalari S; Khajeh A; Inaloo S; Fatehi F; Hosseinpour S; Babaei M; Hosseini SA; Mahdi Hosseiny SM; Fayyazi A; Hosseini F; Toosi MB; Khosroshahi N; Ghabeli H; Biglari HN; Kakhki SK; Mirlohi SH; Bidabadi E; Mohammadi B; Omrani A; Sedighi M; Vafaee-Shahi M; Rasulinezhad M; Hoseini SM; Movahedinia M; Rezaei Z; Karimi P; Farshadmoghadam H; Anvari S; Yaghini O; Nasiri J; Zamani G; Ashrafi MR
J Neuromuscul Dis; 2023; 10(2):211-225. PubMed ID: 36776076
[TBL] [Abstract][Full Text] [Related]
6. Drug treatment for spinal muscular atrophy type I.
Wadman RI; van der Pol WL; Bosboom WM; Asselman FL; van den Berg LH; Iannaccone ST; Vrancken AF
Cochrane Database Syst Rev; 2019 Dec; 12(12):CD006281. PubMed ID: 31825542
[TBL] [Abstract][Full Text] [Related]
7. Nusinersen treatment of Spinal Muscular Atrophy Type 1 - results of expanded access programme in Poland.
Modrzejewska S; Kotulska K; Kopyta I; Grędowska E; Emich-Widera E; Tomaszek K; Paprocka J; Chmielewski D; Pilch J; Pietruszewski J; Lemska A; Zawadzka M; Mazurkiewicz-Bełdzińska M
Neurol Neurochir Pol; 2021; 55(3):289-294. PubMed ID: 33565602
[TBL] [Abstract][Full Text] [Related]
8. Association between the SMN2 gene copy number and clinical characteristics of patients with spinal muscular atrophy with homozygous deletion of exon 7 of the SMN1 gene.
Zarkov M; Stojadinović A; Sekulić S; Barjaktarović I; Perić S; Keković G; Drasković B; Stević Z
Vojnosanit Pregl; 2015 Oct; 72(10):859-63. PubMed ID: 26665550
[TBL] [Abstract][Full Text] [Related]
9. Drug treatment for spinal muscular atrophy types II and III.
Wadman RI; van der Pol WL; Bosboom WM; Asselman FL; van den Berg LH; Iannaccone ST; Vrancken AF
Cochrane Database Syst Rev; 2020 Jan; 1(1):CD006282. PubMed ID: 32006461
[TBL] [Abstract][Full Text] [Related]
10. Improved upper limb function in non-ambulant children with SMA type 2 and 3 during nusinersen treatment: a prospective 3-years SMArtCARE registry study.
Pechmann A; Behrens M; Dörnbrack K; Tassoni A; Wenzel F; Stein S; Vogt S; Zöller D; Bernert G; Hagenacker T; Schara-Schmidt U; Walter MC; Bertsche A; Vill K; Baumann M; Baumgartner M; Cordts I; Eisenkölbl A; Flotats-Bastardas M; Friese J; Günther R; Hahn A; Horber V; Husain RA; Illsinger S; Jahnel J; Johannsen J; Köhler C; Kölbel H; Müller M; von Moers A; Schwerin-Nagel A; Reihle C; Schlachter K; Schreiber G; Schwartz O; Smitka M; Steiner E; Trollmann R; Weiler M; Weiß C; Wiegand G; Wilichowski E; Ziegler A; Lochmüller H; Kirschner J;
Orphanet J Rare Dis; 2022 Oct; 17(1):384. PubMed ID: 36274155
[TBL] [Abstract][Full Text] [Related]
11. Newborn screening for spinal muscular atrophy in Germany: clinical results after 2 years.
Vill K; Schwartz O; Blaschek A; Gläser D; Nennstiel U; Wirth B; Burggraf S; Röschinger W; Becker M; Czibere L; Durner J; Eggermann K; Olgemöller B; Harms E; Schara U; Kölbel H; Müller-Felber W
Orphanet J Rare Dis; 2021 Mar; 16(1):153. PubMed ID: 33789695
[TBL] [Abstract][Full Text] [Related]
12. Cardiac function evaluation in children with spinal muscular atrophy: A case-control study.
He X; Li X; Yan M; Peng H; Zhang L; Liang Y; Tang W; Li S
Pediatr Int; 2024; 66(1):e15769. PubMed ID: 38742693
[TBL] [Abstract][Full Text] [Related]
13. Systematic Literature Review of the Natural History of Spinal Muscular Atrophy: Motor Function, Scoliosis, and Contractures.
Aponte Ribero V; Martí Y; Batson S; Mitchell S; Gorni K; Gusset N; Oskoui M; Servais L; Sutherland CS
Neurology; 2023 Nov; 101(21):e2103-e2113. PubMed ID: 37813581
[TBL] [Abstract][Full Text] [Related]
14. RESTORE: A Prospective Multinational Registry of Patients with Genetically Confirmed Spinal Muscular Atrophy - Rationale and Study Design.
Finkel RS; Day JW; De Vivo DC; Kirschner J; Mercuri E; Muntoni F; Shieh PB; Tizzano E; Desguerre I; Quijano-Roy S; Saito K; Droege M; Dabbous O; Khan F; Renault L; Anderson FA; Servais L
J Neuromuscul Dis; 2020; 7(2):145-152. PubMed ID: 32039859
[TBL] [Abstract][Full Text] [Related]
15. Health-related quality of life of adults with spinal muscular atrophy: insights from a nationwide patient registry in Germany.
Landfeldt E; Leibrock B; Hussong J; Thiele S; Walter MC; Moehler E; Zemlin M; Dillmann U; Flotats-Bastardas M
Qual Life Res; 2024 Jul; 33(7):1949-1959. PubMed ID: 38753126
[TBL] [Abstract][Full Text] [Related]
16. Systematic Literature Review to Assess the Cost and Resource Use Associated with Spinal Muscular Atrophy Management.
Paracha N; Hudson P; Mitchell S; Sutherland CS
Pharmacoeconomics; 2022 Apr; 40(Suppl 1):11-38. PubMed ID: 34761360
[TBL] [Abstract][Full Text] [Related]
17. One Year of Newborn Screening for SMA - Results of a German Pilot Project.
Vill K; Kölbel H; Schwartz O; Blaschek A; Olgemöller B; Harms E; Burggraf S; Röschinger W; Durner J; Gläser D; Nennstiel U; Wirth B; Schara U; Jensen B; Becker M; Hohenfellner K; Müller-Felber W
J Neuromuscul Dis; 2019; 6(4):503-515. PubMed ID: 31594245
[TBL] [Abstract][Full Text] [Related]
18. Multidisciplinary team meetings in treatment of spinal muscular atrophy adult patients: a real-life observatory for innovative treatments.
Salort-Campana E; Solé G; Magot A; Tard C; Noury JB; Behin A; De La Cruz E; Boyer F; Lefeuvre C; Masingue M; Debergé L; Finet A; Brison M; Spinazzi M; Pegat A; Sacconi S; Malfatti E; Choumert A; Bellance R; Bedat-Millet AL; Feasson L; Vuillerot C; Jacquin-Piques A; Michaud M; Pereon Y; Stojkovic T; Laforêt P; Attarian S; Cintas P
Orphanet J Rare Dis; 2024 Jan; 19(1):24. PubMed ID: 38268028
[TBL] [Abstract][Full Text] [Related]
19. The Japan Registry for Adult Subjects of Spinal Muscular Atrophy (jREACT-SMA): Protocol for a Longitudinal Observational Study.
Sahashi K; Hashizume A; Kuwatsuka Y; Chinen M; Saotome-Nakamura A; Ando M; Katsuno M
JMIR Res Protoc; 2022 Dec; 11(12):e38878. PubMed ID: 36520510
[TBL] [Abstract][Full Text] [Related]
20. Effects of nusinersen after one year of treatment in 123 children with SMA type 1 or 2: a French real-life observational study.
Audic F; de la Banda MGG; Bernoux D; Ramirez-Garcia P; Durigneux J; Barnerias C; Isapof A; Cuisset JM; Cances C; Richelme C; Vuillerot C; Laugel V; Ropars J; Altuzarra C; Espil-Taris C; Walther-Louvier U; Sabouraud P; Chouchane M; Vanhulle C; Trommsdorff V; Pervillé A; Testard H; Lagrue E; Sarret C; Avice AL; Beze-Beyrie P; Pauly V; Quijano-Roy S; Chabrol B; Desguerre I
Orphanet J Rare Dis; 2020 Jun; 15(1):148. PubMed ID: 32532349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
